Improving medication safety: Development and impact of a multivariate model-based strategy to target high-risk patients
- PMID: 28192533
- PMCID: PMC5305217
- DOI: 10.1371/journal.pone.0171995
Improving medication safety: Development and impact of a multivariate model-based strategy to target high-risk patients
Abstract
Background: Preventive strategies to reduce clinically significant medication errors (MEs), such as medication review, are often limited by human resources. Identifying high-risk patients to allow for appropriate resource allocation is of the utmost importance. To this end, we developed a predictive model to identify high-risk patients and assessed its impact on clinical decision-making.
Methods: From March 1st to April 31st 2014, we conducted a prospective cohort study on adult inpatients of a 1,644-bed University Hospital Centre. After a clinical evaluation of identified MEs, we fitted and internally validated a multivariate logistic model predicting their occurrence. Through 5,000 simulated randomized controlled trials, we compared two clinical decision pathways for intervention: one supported by our model and one based on the criterion of age.
Results: Among 1,408 patients, 365 (25.9%) experienced at least one clinically significant ME. Eleven variables were identified using multivariable logistic regression and used to build a predictive model which demonstrated fair performance (c-statistic: 0.72). Major predictors were age and number of prescribed drugs. When compared with a decision to treat based on the criterion of age, our model enhanced the interception of potential adverse drug events by 17.5%, with a number needed to treat of 6 patients.
Conclusion: We developed and tested a model predicting the occurrence of clinically significant MEs. Preliminary results suggest that its implementation into clinical practice could be used to focus interventions on high-risk patients. This must be confirmed on an independent set of patients and evaluated through a real clinical impact study.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. Journal of the American Pharmaceutical Association. 2001;41(2):192–9. - PubMed
-
- Pharmaceutical Care Network Europe Foundation. The PCNE Classification V 6.2. 2010.
-
- Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 2005;173(5):510–5. PubMed Central PMCID: PMC1188190. 10.1503/cmaj.045311 - DOI - PMC - PubMed
-
- Basey AJ, Krska J, Kennedy TD, Mackridge AJ. Prescribing errors on admission to hospital and their potential impact: a mixed-methods study. BMJ quality & safety. 2014;23(1):17–25. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
